“…Chemically, it is 5-(4-Chlorophenyl)-1-(2,4-dichloro-phenyl)-4-methyl-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide mono hydrochloride (Figure1), with empirical formula of C 22 H 21 C l3 N 4 O.HCl and the molecular weight of 500.29. Literature review reveals that few analytical methods were evoked for the estimation of RMTH in human plasma (Ramakrishna et al, 2007;Melissa et al, 2008;Fouad et al ., 2009), in human plasma and hair (Stanislas Grassin et al, 2008), in rat plasma (Rajesh et al, 2009), in monkey plasma (Javors et al, 2010), identification of endo cannabinoids and related compounds in fat cells by different analytical techniques (Marie Paule et al, 2007), HPLC method for bio analytical application with rimonabant (Uttam et al, 2009), simultaneous estimation of rimonabant with orlistat (Wei et al, 2010) and with four major species in slimy foods (Zhou et al, 2010) Detection and quantification of synthetic drugs in herbal slimming formula (Sofian et al, 2009) , pharmacokinetic studies of RMTH in rats (Zoe et al, 2006), stability indicating assay of RMTH in bulk and pharmaceutical dosage forms by HPLC (Felipe et al, 2010;Satyanarayana et al, 2009), by HPTLC (Rajesh et al, 2010), estimation of RMTH in bulk and pharmaceutical dosage forms using external standard method (Sreekanth et al, 2009) and spectrophotometric estimation of RMTH in marketed formulations (Manas et al, 2009) were reported. In the absence of official RMTH monograph in the pharmacopoeias, including the European Pharmacopoeia, British Pharmacopoeia and United States Pharmacopoeia, development of such a method may prove all the more useful.…”